4//SEC Filing
Rasdal Andrew P 4
Accession 0001214659-20-005893
CIK 0001427570other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:56 PM ET
Size
8.3 KB
Accession
0001214659-20-005893
Insider Transaction Report
Form 4
Rasdal Andrew P
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-06-23+165,135→ 165,135 totalExercise: $0.73Exp: 2030-06-23→ Common Stock (165,135 underlying) - Award
Stock Option
2020-06-23+52,865→ 52,865 totalExp: 2030-06-23→ Common Stock (52,865 underlying)
Footnotes (2)
- [F1]Each share of Common Stock underlying the cash-settled Option represents the right to a cash payment equal to the excess, if any, of (i) the Fair Market Value of each such share on the date of exercise over (ii) the exercise price per share set forth in the Notice of Stock Option Grant ($0.73), and such Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. This Option may not be exercised for Shares of the Company's Common Stock.
- [F2]The Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001323238
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 6:56 PM ET
- Size
- 8.3 KB